Possibly, both ablation of WBP2 in drug-resistant cancer cells and combination of ER inhibitor and chemotherapy facilitated the absorption of chemotherapy drugs and sensitised ERα-positive drug-resistant cancer cells to chemotherapeutics. Here, WBP2 is linked to cancer.